Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
& Kristensen, K
While GLP-1 is naturally produced by your body, Ozempic is specifically formulated to mimic and amplify the beneficial effects of this hormone
These benefits have been demonstrated in large, well-designed cardiovascular outcome trials, including: Liraglutide (Victoza) the LEADER trial , which showed a significant reduction in cardiovascular death and all-cause mortality Semaglutide (Ozempic) the SUSTAIN-6 trial , demonstrating fewer major adverse cardiovascular events, particularly stroke Dulaglutide (Trulicity) the REWIND trial , which showed a significant reduction in major cardiovascular events even in people without established cardiovascular disease Tirzepatide (Mounjaro) cardiovascular outcome data from the SURPASS-CVOT programme are emerging, with early results suggesting cardiovascular benefit compared with insulin therapy These cardiovascular effects are a key reason why GLP-1based therapies are now recommended earlier in the treatment pathway for people with type 2 diabetes who have established heart disease or are at high cardiovascular risk
Be good to yourself
50 & Target GLP-1 R [1] Chemical Information CAS No
A new plateau tends to appear with time as weight loss slows down
US$ 29.51
US$ 26.76
US$ 29.85
US$ 20.93
US$ 26.49
US$ 25.68
US$ 21.37
US$ 25.75
US$ 27.30
US$ 27.49
US$ 27.50
US$ 20.98
US$ 27.79
